Variant report
Variant | nsv968314 |
---|---|
Chromosome Location | chr5:69206358-69211981 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:102)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr5:69211028-69211228 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr5:69209216-69209435 | GM12878 | blood: | n/a | n/a |
3 | CTCF | chr5:69205884-69206557 | K562 | blood: | n/a | n/a |
4 | CTCF | chr5:69209720-69209870 | BE2_C | brain: | n/a | n/a |
5 | CTCF | chr5:69206005-69206364 | K562 | blood: | n/a | n/a |
6 | EBF1 | chr5:69209017-69209409 | GM12878 | blood: | n/a | n/a |
7 | EP300 | chr5:69211012-69211339 | GM12878 | blood: | n/a | n/a |
8 | FOSL2 | chr5:69206923-69207232 | HepG2 | liver: | n/a | n/a |
9 | FOSL2 | chr5:69209216-69209530 | HepG2 | liver: | n/a | n/a |
10 | FOSL2 | chr5:69208910-69209215 | HepG2 | liver: | n/a | chr5:69209192-69209200 chr5:69209193-69209200 |
11 | FOSL2 | chr5:69208927-69209172 | HepG2 | liver: | n/a | n/a |
12 | FOSL2 | chr5:69211012-69211249 | HepG2 | liver: | n/a | n/a |
13 | FOXA2 | chr5:69209004-69209939 | A549 | lung: | n/a | chr5:69209267-69209279 |
14 | FOXA2 | chr5:69208195-69208910 | A549 | lung: | n/a | n/a |
15 | FOXP2 | chr5:69207418-69207919 | PFSK-1 | brain: | n/a | n/a |
16 | FOXP2 | chr5:69207189-69207396 | PFSK-1 | brain: | n/a | n/a |
17 | GABPA | chr5:69211027-69211325 | Hela-S3 | cervix: | n/a | n/a |
18 | GABPA | chr5:69207112-69207357 | Hela-S3 | cervix: | n/a | n/a |
19 | GABPA | chr5:69208961-69209221 | Hela-S3 | cervix: | n/a | n/a |
20 | GABPA | chr5:69211048-69211167 | Hela-S3 | cervix: | n/a | n/a |
21 | GABPA | chr5:69211916-69212095 | Hela-S3 | cervix: | n/a | n/a |
22 | GATA2 | chr5:69211060-69211337 | K562 | blood: | n/a | n/a |
23 | GATA2 | chr5:69209222-69209462 | K562 | blood: | n/a | chr5:69209324-69209334 |
24 | HEY1 | chr5:69211021-69211312 | K562 | blood: | n/a | n/a |
25 | HEY1 | chr5:69210521-69210772 | HepG2 | liver: | n/a | n/a |
26 | HEY1 | chr5:69209001-69209405 | K562 | blood: | n/a | n/a |
27 | IRF4 | chr5:69209053-69209364 | GM12878 | blood: | n/a | n/a |
28 | JUND | chr5:69209753-69209981 | HepG2 | liver: | n/a | n/a |
29 | JUND | chr5:69211874-69212055 | HepG2 | liver: | n/a | n/a |
30 | JUND | chr5:69209042-69209460 | HepG2 | liver: | n/a | chr5:69209192-69209200 chr5:69209193-69209200 |
31 | PAX5 | chr5:69211033-69211315 | GM12878 | blood: | n/a | n/a |
32 | PAX5 | chr5:69209207-69209374 | GM12878 | blood: | n/a | n/a |
33 | PAX5 | chr5:69211838-69212470 | GM12878 | blood: | n/a | n/a |
34 | PAX5 | chr5:69210562-69210958 | GM12878 | blood: | n/a | n/a |
35 | PAX5 | chr5:69210972-69211395 | GM12878 | blood: | n/a | n/a |
36 | PAX5 | chr5:69211094-69211260 | GM12878 | blood: | n/a | n/a |
37 | PAX5 | chr5:69211017-69211312 | GM12878 | blood: | n/a | n/a |
38 | PAX5 | chr5:69209858-69210030 | GM12878 | blood: | n/a | n/a |
39 | PAX5 | chr5:69211868-69212047 | GM12878 | blood: | n/a | n/a |
40 | PAX5 | chr5:69208982-69209206 | GM12878 | blood: | n/a | n/a |
41 | PBX3 | chr5:69211337-69211450 | GM12878 | blood: | n/a | n/a |
42 | PBX3 | chr5:69209792-69209924 | GM12878 | blood: | n/a | n/a |
43 | PBX3 | chr5:69208643-69208834 | GM12878 | blood: | n/a | n/a |
44 | PBX3 | chr5:69211038-69211246 | GM12878 | blood: | n/a | n/a |
45 | POLR2A | chr5:69209772-69209801 | K562 | blood: | n/a | n/a |
46 | POLR2A | chr5:69207106-69207348 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | POLR2A | chr5:69208966-69209215 | GM12878 | blood: | n/a | n/a |
48 | POLR2A | chr5:69209724-69210030 | GM12878 | blood: | n/a | n/a |
49 | POLR2A | chr5:69211763-69212460 | GM12878 | blood: | n/a | n/a |
50 | POLR2A | chr5:69208915-69209512 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000198237 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563156921 | chr5:69206546-69206547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530258271 | chr5:69206547-69206548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199599183 | chr5:69206558-69206559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200509451 | chr5:69206564-69206565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62374347 | chr5:69206565-69206566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79855891 | chr5:69206569-69206570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs80196545 | chr5:69206573-69206574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375925859 | chr5:69206624-69206625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62374348 | chr5:69207947-69207948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566891347 | chr5:69209198-69209199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111876451 | chr5:69209537-69209538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368996521 | chr5:69209562-69209563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142445162 | chr5:69209576-69209577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373090490 | chr5:69209739-69209740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376806514 | chr5:69209796-69209797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200196223 | chr5:69209830-69209831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369795330 | chr5:69210014-69210015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62374349 | chr5:69210362-69210363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs891826 | chr5:69210586-69210587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs833569 | chr5:69210743-69210744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:69202000-69211400 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
2 | chr5:69208600-69211000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr5:69208600-69211000 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
4 | chr5:69208600-69211000 | Weak transcription | Thymus | Thymus |
5 | chr5:69209800-69210000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr5:69209800-69210000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |